Double-blind Multicenter Placebo-controlled Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer
The goal of this trial is to assess the safety, therapeutic dose, and leukostimulatory activity of the preparation Panagen in the therapeutic schemes for treating cancer diseases in the patients receiving a standard chemotherapy for breast cancer of stages II-IV (with distant metastases).
100 Clinical Results associated with Panagen, Limited Liability Company
0 Patents (Medical) associated with Panagen, Limited Liability Company
100 Deals associated with Panagen, Limited Liability Company
100 Translational Medicine associated with Panagen, Limited Liability Company